Clinical Trial of Recombinant COVID-19 Vaccine (Sf9 Cells) in Children and Adolescents

NCT05013983 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Clinical trials not conducted

Conditions

COVID-19

Interventions

BIOLOGICAL: Recombinant COVID-19 vaccine (Sf9 cells)
OTHER: Placebo control

Sponsor

WestVac Biopharma Co., Ltd.

Collaborators

[object Object]